KANGSTEM BIOTECH CO., LTD.

Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.

217730 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강남구 테헤란로 522 홍우빌딩 9층, 강남구
Website:: https://kangstem.com
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kangstem Biotech Co., Ltd. is a biopharmaceutical company dedicated to the research and development of stem cell therapeutics for rare and incurable diseases. The company's core mission is to address unmet medical needs through innovative, next-generation biopharmaceuticals. In addition to its therapeutic pipeline, Kangstem Biotech operates several key business segments. These include the production and commercialization of specialized stem cell culture media and mediums, noted for their efficacy in mesenchymal stem cell proliferation. The company also provides a proprietary cell freezing and thawing platform and offers Contract Development and Manufacturing Organization (CDMO) services, leveraging its expertise in cell-based technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KANGSTEM BIOTECH CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all KANGSTEM BIOTECH CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for KANGSTEM BIOTECH CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ChoA Pharmaceutical Co., LTD. Global manufacturer of OTC medicines and health supplements distributed through pharmacies.	South Korea	034940
CHUGAI PHARMACEUTICAL CO., LTD. An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.	Japan	4519
Cinclus Pharma Holding AB Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.	Sweden	CINPHA
Circio Holding ASA Developing circular RNA vector tech and immunotherapies for gene and cell therapies.	Norway	CRNA
CJ Bioscience Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.	South Korea	311690
CKD Bio Corp. Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.	South Korea	063160
CMG Pharmaceutical Co., Ltd. Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.	South Korea	058820
co.don AG Develops personalized cartilage cell transplants for minimally invasive joint repair.	Germany	CNW
Compugen Ltd. Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.	Israel	CGEN
CORESTEMCHEMON Inc. Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.	South Korea	166480